A study assessing CT angiographs of nearly 25,000 patients presumed to be free of coronary artery disease (CAD) has shown both obstructive and nonobstructive forms of the disease to increase the risk of death.
A study assessing CT angiographs of nearly 25,000 patients presumed to be free of coronary artery disease (CAD) has shown both obstructive and nonobstructive forms of the disease to increase the risk of death.
The study, published August 16 in the Journal of the American College of Cardiology, used data from CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry). The cohort included 24,775 patients from 12 centers, average age 57. From 2005 to 2009, all underwent noninvasive imaging with coronary computed tomography angiography (CCTA).
Researches led by radiologist James K. Min, MD, of Cedars-Sinai Medical Center in Los Angeles, Calif., followed up 2.3 years after the patients’ CT angiographs. At that point, 404 of the patients had died of various causes. Min and colleagues found that patients who indeed had been healthy - that is, no discernable CAD in CT angiographs - had a low annualized death rate of 0.28 percent.
Those with nonobstructive and obstructive CAD fared worse. Those with nonobstructive CAD had hazard ratios averaging 1.62 (that is, a risk of death 62 percent higher than healthy controls in the 2.3-year time frame assessed). Those with one obstructed vessel had a hazard ratio (HR) of 2.0, those with two obstructed vessels 2.92, and those with three obstructed vessels 3.70.
Min and colleagues also found that patients younger than 65 years old had higher death rates for two- and three-vessel obstructive CAD, possibly because of more aggressive forms of atherosclerosis. Also, the study found that women with three-vessel obstructions faced more serious risk than men.
“That coronary CT angiography can effectively risk stratify individuals without known CAD should be invaluable for guiding the development of clinical practice guidelines and appropriate use criteria,” the authors concluded.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.